Yearly Archives: 2026

Community Pharmacy England has launched a new patient-facing website to promote several of the key Advanced services that pharmacy teams provide and to direct patients to pharmacies in England that provide these services. The website (communitypharmacy.org.uk) provides information about the following three services: Pharmacy First Service (clinical pathways); Hypertension Case-Finding Service (publicly known as the [...]

The post New patient-facing website to promote NHS pharmacy clinical services appeared first on Community Pharmacy England.

Community Pharmacy England has published new guidance to help community pharmacy owners complete the Data Security and Protection Toolkit (DSPTK) 2026. The Toolkit is used to make a pharmacy’s information governance (IG) declaration and must be completed by Tuesday 30th June 2026. Community Pharmacy England has collaborated with the NHS DSPTK team to keep the workload associated [...]

The post Data Security & Protection Toolkit 2026: Community Pharmacy England guidance available appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: Fingolimod Glenmark 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) Drug Alert Number: EL(26)A/02 Date issued: 21 January 2026 Glenmark Pharmaceuticals Europe Limited is recalling one batch after stability testing showed out-of-specification results. The batch is being recalled as a precautionary measure following test results that showed a delay in capsule [...]

The post MHRA Class 3 Medicines Recall: Fingolimod Glenmark 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) appeared first on Community Pharmacy England.

The second 2025/26 national health campaign starts in just over a weeks time (Monday 2nd February 2026). All pharmacies will need to participate in the campaign, using relevant materials to promote the Pharmacy First service to the public. How to meet the requirements of the campaign Pharmacy owners can meet the requirements of the campaign [...]

The post Second national health campaign starts soon appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Paliperidone Mercury Pharma prolonged-release suspension for injection in pre-filled syringes Drug alert number: EL(26)A/01 Date issued: 20 January 2026 Mercury Pharmaceuticals Ltd is recalling remaining stock of paliperidone pre-filled syringes as a precautionary measure due to Good Manufacturing Practice (GMP) deficiencies cited during a recent inspection at the finished product [...]

The post MHRA Class 2 Medicines Recall: Paliperidone Mercury Pharma prolonged-release suspension for injection in pre-filled syringes appeared first on Community Pharmacy England.